SBM Life Sciencesp. z o.o.

Wholesale of chemical products

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2016-06-27
Share capital
5,000.00 PLN
Registered address
ul. Bonifraterska 17, 00-203 Warszawa, Poland

Financials

Revenue history (in k)

Filing timeliness

3 of 6 financial statements were filed late (the longest delay 181 days for 2025).

  • 202513/10/2026
  • 202405/08/2025
  • 202326/03/2024
  • 202230/03/2023
  • 202117/01/2022
  • 202002/08/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 6.18mMedianUSD 895.43kAverageUSD 9.80m
Net profit
This companyUSD -248.08kMedianUSD 19.07kAverageUSD 341.02k
Operating costs
This companyUSD 5.81mMedianUSD 832.62kAverageUSD 8.90m
Assets
This companyUSD 3.67mMedianUSD 474.63kAverageUSD 5.34m

Trademarks

SBM Life Science currently holds no active trademarks with the Polish Patent Office. 2 marks have expired or were not registered. The first mark was filed in 2020.

MarkNumberClassesStatusProtected until
EASY HERBSZ.5107271, 31Proceedings discontinued –
EASY SALADZ.5107281, 31Proceedings discontinued –
MarkProtected until
EASY HERBS–
EASY SALAD–

Authorized Representatives

Alexandre Pierre Simmler – Management Board Member

Manner of representation

Each member of the management board is authorized to represent the company independently.

Ownership

OwnerSharesShare valueStake
Sbm Jardin
100$1,350.62100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2016-07-01.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Buildings and premises
PLN 16,901

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Chem4polsp. z o.o.
Bestpharmasp. z o.o.
Bioagrissp. z o.o. + limited partnership
Ormeasp. z o.o.
Chemix Groupsp. z o.o.
Grafia K. Dziewulskasp. j.
Grosschemsp. z o.o.
Killgerm Polskasp. z o.o.
Medicossp. z o.o.
Sterilcosp. z o.o.

Change history

DateEvent
2016-10-12Address change
2016-06-27Entered in the register

FAQ

Last updated: 2026-10-13